Immunoparesis in newly diagnosed Multiple Myeloma patients: Effects on overall survival and progression free survival in the Danish population.

MLA

Sørrig, Rasmus, et al. “Immunoparesis in Newly Diagnosed Multiple Myeloma Patients: Effects on Overall Survival and Progression Free Survival in the Danish Population.” PloS One, vol. 12, no. 12, Dec. 2017, p. e0188988. EBSCOhost, https://doi.org/10.1371/journal.pone.0188988.

APA

Sørrig, R., Klausen, T. W., Salomo, M., Vangsted, A. J., Frølund, U. C., Andersen, K. T., Klostergaard, A., Helleberg, C., Pedersen, R. S., Pedersen, P. T., Helm-Petersen, S., Teodorescu, E. M., Preiss, B., Abildgaard, N., & Gimsing, P. (2017). Immunoparesis in newly diagnosed Multiple Myeloma patients: Effects on overall survival and progression free survival in the Danish population. PloS One, 12(12), e0188988. https://doi.org/10.1371/journal.pone.0188988

Chicago

Sørrig, Rasmus, Tobias W Klausen, Morten Salomo, Annette J Vangsted, Ulf Christian Frølund, Kristian T Andersen, Anja Klostergaard, et al. 2017. “Immunoparesis in Newly Diagnosed Multiple Myeloma Patients: Effects on Overall Survival and Progression Free Survival in the Danish Population.” PloS One 12 (12): e0188988. doi:10.1371/journal.pone.0188988.